These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1373305

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073).
    Di Salle E, Briatico G, Giudici D, Ornati G, Panzeri A.
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):241-8. PubMed ID: 8142301
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
    Liang T, Heiss CE.
    J Biol Chem; 1981 Aug 10; 256(15):7998-8005. PubMed ID: 7263637
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
    Li X, Singh SM, Labrie F.
    J Med Chem; 1995 Mar 31; 38(7):1158-73. PubMed ID: 7707319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
    Liang T, Rasmusson GH, Brooks JR.
    J Steroid Biochem; 1983 Jul 31; 19(1A):385-90. PubMed ID: 6887871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. FK143, a novel nonsteroidal inhibitor of steroid 5 alpha-reductase: (2) In vivo effects on rat and dog prostates.
    Hirosumi J, Nakayama O, Chida N, Inami M, Fagan T, Sawada K, Shigematsu S, Kojo H, Notsu Y, Okuhara M.
    J Steroid Biochem Mol Biol; 1995 Apr 31; 52(4):365-73. PubMed ID: 7734405
    [Abstract] [Full Text] [Related]

  • 12. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
    Labrie C, Trudel C, Li S, Martel C, Couêt J, Labrie F.
    Endocrinology; 1991 Jul 31; 129(1):566-8. PubMed ID: 2055205
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
    Youn DH, Park J, Kim HL, Jung Y, Kang J, Jeong MY, Sethi G, Seok Ahn K, Um JY.
    Oncotarget; 2017 Feb 07; 8(6):9500-9512. PubMed ID: 27880726
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of some 4-fluoro- and 4-cyano derivatives of delta 4,3-ketosteroids as inhibitors of testosterone 5 alpha-reductase.
    Jarman M, Barrie SE, Houghton J, Rowlands MG, Mann J, Haase-Held M, Hatzis M.
    J Enzyme Inhib; 1994 Feb 07; 8(1):17-23. PubMed ID: 7539066
    [Abstract] [Full Text] [Related]

  • 19. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
    Bratoeff E, Cabeza M, Pérez-Ornelas V, Recillas S, Heuze I.
    J Steroid Biochem Mol Biol; 2008 Sep 07; 111(3-5):275-81. PubMed ID: 18644453
    [Abstract] [Full Text] [Related]

  • 20. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations.
    Ghusn HF, Shao TC, Klima M, Cunningham GR.
    J Androl; 1991 Sep 07; 12(5):315-22. PubMed ID: 1765567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.